Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Reaching the 2 billion: The Japanese pharmaceutical industry and access to medicine

A commentary by Jayasree K. Iyer and Danny Edwards, on the increasing orientation of Japan towards global health issues, and the growing contribution of the the Japanese pharmaceutical industry towards achieving access to medicine goals.

Date

11 January 2016

Download this publication

There is an on-going challenge to the global community: ensuring quality, affordable, accessible healthcare to people living in developing countries. It is estimated that two billion people lack access to essential medicines, vaccines and diagnostics, with most of these people living in resource-poor settings. Governments, non-government organisations (NGOs), and private sector organisations need to all coordinate activities to ensure that products and solutions reach the people who need them.

As the innovators and producers of key medicines, vaccines and diagnostics, the pharmaceutical industry has a central role in alleviating this burden. However, industry must be supported in turn by the other stakeholders: governments have a role in creating a supportive environment for companies to development products for the poor, and NGOs identify and communicate pressing issues, and have intimate knowledge of needs and gaps.



Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved